170 related articles for article (PubMed ID: 14979202)
1. [Serum PSA and transition zone index as predictors of acute urinary retention in benign prostate hyperplasia].
Zhu S; Chen S; Li Q; Lin Z; Zheng S; Weng M
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):24-5. PubMed ID: 14979202
[TBL] [Abstract][Full Text] [Related]
2. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
Gao ZW; Liu G; Sheng BW
Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
[TBL] [Abstract][Full Text] [Related]
3. [The effect of acute urinary retention on serum prostate specific antigen concentration].
Hua LX; Wu HF; Sui YG; Cheng SG; Xu ZQ
Zhonghua Nan Ke Xue; 2002; 8(2):134-5. PubMed ID: 12479031
[TBL] [Abstract][Full Text] [Related]
4. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Lief JH; Hinerman-Mulroy A; Galbreath RW
Brachytherapy; 2003; 2(3):181-8. PubMed ID: 15062141
[TBL] [Abstract][Full Text] [Related]
6. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
[TBL] [Abstract][Full Text] [Related]
7. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
8. Definition of at-risk patients: dynamic variables.
Emberton M
BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of acute urine retention in patients with benign prostate hyperplasia].
Zhang Y; He L; Long Z; Sun X; Wang G; Pei X; Zhong K; Ye Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):300-4. PubMed ID: 22561500
[TBL] [Abstract][Full Text] [Related]
10. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
Dutkiewicz S; Stepień K; Witeska A
Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
[TBL] [Abstract][Full Text] [Related]
11. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
Roehrborn CG; McConnell JD; Lieber M; Kaplan S; Geller J; Malek GH; Castellanos R; Coffield S; Saltzman B; Resnick M; Cook TJ; Waldstreicher J
Urology; 1999 Mar; 53(3):473-80. PubMed ID: 10096369
[TBL] [Abstract][Full Text] [Related]
12. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
Roehrborn CG
BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
[TBL] [Abstract][Full Text] [Related]
13. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
14. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
Tuncel A; Uzun B; Eruyar T; Karabulut E; Seckin S; Atan A
Eur Urol; 2005 Aug; 48(2):277-83; discussion 283-4. PubMed ID: 15964132
[TBL] [Abstract][Full Text] [Related]
15. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia.
Shinbo H; Kurita Y; Takada S; Imanishi T; Otsuka A; Furuse H; Nakanishi T; Mugiya S; Ozono S
Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746
[TBL] [Abstract][Full Text] [Related]
16. Holmium laser prostatic resection for patients presenting with acute urinary retention.
Anderson CB; Helfand BT; McVary KT
BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
[TBL] [Abstract][Full Text] [Related]
17. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
18. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of PSAD and PSAD-TZ value in prostatic hyperplasia and prostatic cancer].
Fu Q; Yao DH; Jiang YQ
Zhonghua Nan Ke Xue; 2002 Dec; 8(6):411-3. PubMed ID: 12593013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
